|
Erythrocin StearateDrug - Erythrocin Stearate The trade name of the product as shown on the labeling.
Dosage -
TABLET; ORAL
Active Ingredient(s) -
Erythromycin Stearate
Strength -
EQ 250MG BASE
Applicant -
ABBOTT
New Drug Application (NDA) Number -
060359
Product Number -
001
Therapeutic Equivalence (TE) Code -
AB
Approval Date -
Approved Prior to Jan 1, 1982
Reference Listed Drug (RLD) -
No
Type -
RX
Applicant Full Name -
Abbott Laboratories Pharmaceutical Products Div
Erythrocin Stearate
Erypar Eq 250mg Base Tablet; Oral
Erypar Eq 500mg Base Tablet; Oral Erypar Eq 250mg Base Tablet; Oral Erythrocin Stearate Eq 125mg Base Tablet; Oral Erythrocin Stearate Eq 250mg Base Tablet; Oral Erythromycin Lactobionate Eq 500mg Base/vial Injectable; Injection Erythromycin Lactobionate Eq 1gm Base/vial Injectable; Injection Erythromycin Lactobionate Eq 500mg Base/vial Injectable; Injection Bristamycin Eq 250mg Base Tablet; Oral Bristamycin Eq 250mg Base Tablet; Oral NewDrugInformation |